Form 4: RXO Director Adrian Kingshott Receives RSU Grant

RXO, Inc. Director Adrian Kingshott was granted 14,517 Restricted Stock Units, vesting in 2027, and deferred 7,745 previously vested units.

Summary

• Adrian Kingshott, a Director of RXO, Inc., was granted 14,517 Restricted Stock Units (RSUs) on January 2, 2026.
• Each RSU represents a contingent right to receive either one share of Common Stock or a cash payment equal to the fair market value of one share of Common Stock upon settlement.
• These 14,517 RSUs are scheduled to vest in full on January 2, 2027, contingent on Mr. Kingshott's continued service as a director.
• The filing also indicates that 7,745 underlying shares of Common Stock from previously vested RSUs (which vested on January 2, 2026) have been subjected to a deferral election.
• Following these transactions, Mr. Kingshott beneficially owns 148,522 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of director equity compensation, which is generally a neutral event. The grant of RSUs aligns director interests with shareholders, and the deferral of vested units shows continued commitment, which are mildly positive signals, but it is not a significant market-moving event.

Positives

• The grant of 14,517 Restricted Stock Units aligns the director's interests with long-term shareholder value.
• The deferral election for 7,745 previously vested RSUs indicates a continued commitment to holding company equity.

Risks

• The vesting of the 14,517 RSUs is subject to the reporting person's continued service as a director, meaning forfeiture if service ceases before the January 2, 2027 vesting date.

Future Outlook

The 14,517 Restricted Stock Units are scheduled to vest on January 2, 2027, contingent on the director's continued service. Shares from both the new grant and previously vested units will be delivered according to deferral elections.

Industry Context

This filing represents a routine equity compensation grant to a director, which is a common practice across publicly traded companies to align executive and director incentives with shareholder interests.

Comparison to Industry Standards

• Equity compensation in the form of Restricted Stock Units (RSUs) is a standard practice for director remuneration in U.S. public companies, similar to practices at peers within the transportation and logistics sector.
• The deferral of vested shares is also a common mechanism for directors to manage tax implications and demonstrate long-term commitment, comparable to practices seen at other publicly traded companies.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value, potentially encouraging decisions that benefit the stock price.

Next Steps

• The 14,517 RSUs are expected to vest on January 2, 2027, assuming continued service.
• Shares from both the newly granted and previously vested RSUs will be delivered to the reporting person as per the terms of their deferral elections.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director and the deferral of previously vested units. While the RSU grant aligns the director's interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for RXO, Inc. It is a standard compensation event and does not warrant a change in investment recommendation based solely on this filing.

Keywords

RXO, Adrian Kingshott, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Form 4, Equity Grant, Stock Deferral